SMED EJENDOMME A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  1.1% 1.2% 0.8% 0.8% 1.4%  
Credit score (0-100)  86 81 91 92 77  
Credit rating  A A AA AA A  
Credit limit (kDKK)  1,455.3 475.2 1,848.2 1,881.6 168.3  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9

Net sales  0 0 0 0 0  
Gross profit  2,675 1,261 1,395 1,628 1,445  
EBITDA  2,098 -401 278 512 768  
EBIT  798 943 257 423 -1,044  
Pre-tax profit (PTP)  507.9 150.0 442.5 733.7 -789.1  
Net earnings  319.1 71.1 395.7 571.7 -604.6  
Pre-tax profit without non-rec. items  508 150 443 734 -789  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9

Tangible assets total  38,168 39,512 39,900 40,000 38,200  
Shareholders equity total  20,158 20,229 20,625 21,196 20,592  
Interest-bearing liabilities  24,736 28,918 27,387 26,481 25,703  
Balance sheet total (assets)  66,873 52,416 50,759 51,018 49,313  

Net Debt  -3,511 24,010 25,459 25,228 25,336  
 
See the entire balance sheet

Volume 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  2,675 1,261 1,395 1,628 1,445  
Gross profit growth  -1.7% -52.9% 10.6% 16.7% -11.2%  
Employees  2 2 2 2 2  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  66,873 52,416 50,759 51,018 49,313  
Balance sheet change%  -1.3% -21.6% -3.2% 0.5% -3.3%  
Added value  804.7 949.5 268.7 435.0 -1,044.2  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -28,862 1,338 376 100 -1,800  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 -1.0  

Profitability 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  29.9% 74.8% 18.4% 26.0% -72.3%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  1.2% 1.7% 1.1% 1.7% -0.9%  
ROI %  1.2% 1.7% 1.1% 1.7% -0.9%  
ROE %  1.6% 0.4% 1.9% 2.7% -2.9%  

Solidity 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Equity ratio %  30.2% 38.6% 40.7% 41.6% 41.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -167.3% -5,994.6% 9,172.9% 4,930.0% 3,298.5%  
Gearing %  122.7% 143.0% 132.8% 124.9% 124.8%  
Net interest  0 0 0 0 0  
Financing costs %  1.1% 3.2% 0.5% 0.4% 1.4%  

Liquidity 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Quick Ratio  2.0 4.7 7.2 5.8 6.3  
Current Ratio  1.9 4.7 6.9 5.6 6.2  
Cash and cash equivalent  28,247.1 4,908.1 1,927.2 1,252.7 367.2  

Capital use efficiency 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  13,944.9 10,129.6 9,296.1 9,048.9 9,333.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Net sales / employee  0 0 0 0 0  
Added value / employee  402 475 134 217 -522  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  1,049 -200 139 256 384  
EBIT / employee  399 472 128 212 -522  
Net earnings / employee  160 36 198 286 -302